Structural characterization of disease-causing mutations on SAP and the functional impact on the SLAM peptide: a molecular dynamics approach.

Mol Biosyst

Bioinformatics Division, School of Biosciences and Technology, VIT University, Vellore 632014, Tamil Nadu, India.

Published: July 2014

X-linked lymphoproliferative (XLP) syndrome is an extremely rare inherited immunodeficiency disease characterized by severe immune dysregulation caused by mutations in signaling lymphocyte activation molecule (SLAM) associated protein (SAP) gene. The XLP syndrome was manifested due to dysfunction of SAP as a result of amino acid substitution. Hence, to understand the molecular aspects of the XLP syndrome, we structurally characterized two observed mutations, R32Q and T53I on SAP through the systematic molecular dynamics (MD) approach. Our MD analysis showed that mutant structures elucidated an atomic level variation influenced by mutations that substantially altered the residual flexibility and more importantly the hot spot residues as well in unbound and bound systems. In addition, change in residual flexibility of mutant structures showed an unusual conformational behavior associated with their molecular recognition function compared to the wild-type SAP in both systems. Besides, both mutant structures established different secondary structural profiles during the course of the simulation period in both systems. Moreover, the docking analysis revealed that mutant R32Q and T53I structures displayed remarkably reduced levels of binding affinity to the unphosphorylated SLAM peptide with respect to their docking scores. Collectively, our findings provide knowledge to understand the structural and functional relationship of disease-causing mutations, R32Q and T53I on SAP as well as gain further insights into the molecular pathogenesis of the XLP syndrome.

Download full-text PDF

Source
http://dx.doi.org/10.1039/c4mb00177jDOI Listing

Publication Analysis

Top Keywords

xlp syndrome
16
r32q t53i
12
mutant structures
12
disease-causing mutations
8
slam peptide
8
molecular dynamics
8
dynamics approach
8
mutations r32q
8
t53i sap
8
residual flexibility
8

Similar Publications

Inborn errors of immunity and its clinical significance in children with lymphoma in China: a single-center study.

J Pediatr (Rio J)

June 2024

Medical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Clinical Discipline of Pediatric Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China. Electronic address:

Article Synopsis
  • A study investigated the occurrence and characteristics of pediatric lymphoma patients in China with inborn errors of immunity (IEI)-related gene mutations, revealing these mutations are more common than previously thought.
  • Out of 108 children examined, 17 (15.7%) had IEI mutations, which affected their immune response and led to increased rates of infection and worse treatment outcomes compared to those without such mutations.
  • The findings suggest that understanding genetic factors and medical histories in lymphomas can help in early diagnosis and treatment for children with IEI-related issues.
View Article and Find Full Text PDF
Article Synopsis
  • X-linked lymphoproliferative syndrome (XLP) is a rare genetic immune deficiency with two types: XLP-1 and XLP-2, identified in a study of 7 patients from a Pediatric Immunodeficiency Clinic.
  • Patients were diagnosed at an average age of 3.8 years, with many experiencing recurrent infections and episodes of hemophagocytic lymphohistiocytosis (HLH), particularly in those with XLP-2.
  • Genetic analysis revealed known and novel gene variants, leading to various treatments, including immunoglobulin therapy and stem cell transplantation; however, one patient with XLP-2 and Wiskott-Aldrich syndrome died from pneumonia.
View Article and Find Full Text PDF

When treating patients with EBV encephalitis, the possibility of XLP should be considered. Once the diagnosis of XLP is made, aggressive treatment such as rituximab, and other immunosuppressive agents are desired for rapid transition to HSCT.

View Article and Find Full Text PDF

Background: Phosphorylation of diacylglycerol by diacylglycerol-kinases represents a major inhibitory event constraining T cell activation upon antigen engagement. Efficient TCR signalling requires the inhibition of the alpha isoform of diacylglycerol kinase, DGKα, by an unidentified signalling pathway triggered by the protein adaptor SAP. We previously demonstrated that, in SAP absence, excessive DGKα activity makes the T cells resistant to restimulation-induced cell death (RICD), an apoptotic program counteracting excessive T cell clonal expansion.

View Article and Find Full Text PDF

Genomic medicine enables the identification of patients with rare or ultra-rare monogenic forms of inflammatory bowel disease (IBD) and supports clinical decision making. Patients with monogenic IBD frequently experience extremely early onset of treatment-refractory disease, with complex extraintestinal disease typical of immunodeficiency. Since more than 100 monogenic disorders can present with IBD, new genetic disorders and variants are being discovered every year, and as phenotypic expression of the gene defects is variable, adaptive genomic technologies are required.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!